This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Th1 cytokines in pediatric acute lymphoblastic leukemia
Cancer Immunology, Immunotherapy Open Access 23 August 2023
-
Insights into the mechanism of Arnebia euchroma on leukemia via network pharmacology approach
BMC Complementary Medicine and Therapies Open Access 27 October 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Kobayashi D, Watanabe N, Yamauchi N, Tsuji N, Sato T, Niitsu Y . Endogenous tumor necrosis factor as a predictor of doxorubicin sensitivity in leukemic patients. Blood 1997; 89: 2472–2479.
Zhou M, Findley HW, Ma L, Zaki S, Hill T, Hamid M, Hooper C, Ragab A . Effect of tumor necrosis factor-a on the proliferation of leukemic cells from children with B-cell precursor-acute lymphoblastic leukemia (BCP-ALL): studies of primary leukemic cells and BCP-ALL cell lines. Blood 1991; 77: 2002–2007.
Zhou M, Yeager AM, Smith SD, Findley HW . Overexpression of the MDM2 gene by childhood acute lymphoblastic leukemia cells expressing the wild-type p53 gene. Blood 1995; 85: 1608–1614.
Findley WH, Gu L, Yeager AM, Zhou M . Expression and regulation of Bcl-2, Bcl-xl and Bax correlate with p53 status and sensitivity to apoptosis in childhood acute lymphoblastic leukemia. Blood 1997; 89: 2986–2993.
Sugarman B, Aggarwal B, Hass T, Figari I, Paladino M . Recombinant human tumor necrosis factor: effects on proliferation of normal and transformed cells. Science 1985; 230: 943–945.
Tartaglia LA, Weber RF, Figari IS, Reynolds C, Palladino Jr MA, Goeddel DV . The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci USA 1991; 88: 9292–9296.
Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner D . NF-kB activation by tumor necrosis factor requires the Akt serine-threonine kinase. Nature 1999; 40: 82–85.
Fontaine V, Mohand-Said S, Hanoteau N, Fuchs C, Pfizenmaier K, Eisel U . Neurodegeneration and neuroprotection effects of tumor necrosis factor (TNF) in retinal ischema: opposite roles of TNF receptor 1 and TNF receptor 2. J Neurosci 2002; 22: RC216.
Acknowledgements
This work was supported by grants from the NCI-NIH (R01 CA82323), The Leukemia and Lymphoma Society (6249-05) and CURE Childhood Cancer Inc.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gu, L., Findley, H., Zhu, N. et al. Endogenous TNFα mediates cell survival and chemotherapy resistance by activating the PI3K/Akt pathway in acute lymphoblastic leukemia cells. Leukemia 20, 900–904 (2006). https://doi.org/10.1038/sj.leu.2404160
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404160
This article is cited by
-
Th1 cytokines in pediatric acute lymphoblastic leukemia
Cancer Immunology, Immunotherapy (2023)
-
Insights into the mechanism of Arnebia euchroma on leukemia via network pharmacology approach
BMC Complementary Medicine and Therapies (2020)